Page last updated: 2024-10-18

dihydroxyphenylalanine and Retroperitoneal Neoplasms

dihydroxyphenylalanine has been researched along with Retroperitoneal Neoplasms in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dy, V1
Watson, RC1
Exelby, PR1
Hajdu, SI1
Helson, L1
Kharchenko, AD1
Kniazev, IuA1
Bukhny, AE1
Kovalev, GP1
Kosiakov, GA1

Other Studies

2 other studies available for dihydroxyphenylalanine and Retroperitoneal Neoplasms

ArticleYear
Improved management of stage III neuroblastoma.
    Clinical bulletin, 1979, Volume: 9, Issue:2

    Topics: Age Factors; Antineoplastic Agents; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Human

1979
[Diurnal urine excretion of catecholamines and DOPA in tumors of the sympathetic nervous system in children].
    Pediatriia, 1969, Volume: 48, Issue:5

    Topics: Adolescent; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Lymphom

1969